Close

Harnessing Data Science Insights to Drive OSD Innovation

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

BioPharma Drug Development Workflow and Techniques

Drug development is a long and complex process that...

How to accelerate GMP readiness

With the growing number of clinical trials and new...

Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis

Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases...

Overcoming Challenges in Scale-Up Production

Scaling up production in the pharmaceutical industry is crucial...

Oral solid dosage (OSD) formats offer convenient administration as well as accurate and uniform dosing, which has contributed to their continued popularity and their status as the most globally used drug form [1]. The demand for OSD drugs is still rising, with various new formulation techniques being explored. Recently, data science capabilities have helped to enable the administration of biologics as OSD [2].

Data science facilitates the extraction of meaningful insights from vast datasets. It has been aiding drug development by simplifying integral processes, such as tech transfer or adaptation to different equipment and scales.

As demand for OSD grows, data science is increasingly used to address the issues facing developers and manufacturers throughout product development. These challenges include navigating cost pressures and demands to reduce timelines, as well as the inherent scientific obstacles encountered in manufacturing, such as:

  • Managing drug instability
  • Addressing absorption issues
  • Ensuring consistent drug delivery
  • Navigating regulatory requirements

Poised to continue influencing the entire spectrum of drug production activities, data science is set to be used for in silico models to support product development and optimisation of engineering-driven facility planning, offering a holistic perspective throughout drug quality assurance. These data insights will reduce deviations while fine-tuning planned processes and will expedite the OSD trajectory from initial development to commercialisation.

References

1. https://www.mantellassociates.com/blog/2021/06/oral-solid-dosage-forms-and-why-they-dominate-the-market?source=google.com
2. https://www.europeanpharmaceuticalreview.com/news/174977/osd-contract-manufacturing-market-valued-at-54-7-billion-by-2030/

Author
Author Image
Uwe Hanenberg
Recipharm

Head of Product Development, Oral Solid Dose, Recipharm

Recipharm
Company Logo

Latest stories

Related stories

BioPharma Drug Development Workflow and Techniques

Drug development is a long and complex process that...

How to accelerate GMP readiness

With the growing number of clinical trials and new...

Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis

Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases...

Overcoming Challenges in Scale-Up Production

Scaling up production in the pharmaceutical industry is crucial...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back